Geron Corporation: Commercial Performance Could Dovetail With IMpactMF Run-Up
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Geron Corporation (GERN) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
After Plunging 26.6% in 4 Weeks, Here's Why the Trend Might Reverse for Geron (GERN)
Geron to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference
Geron: Time To Reconsider This Oversold Biotech
Geron (GERN) Loses 21.2% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Geron Corporation (GERN) Presents at Bank of America Global Healthcare Conference 2026 Transcript
First Real-World Evidence Study of RYTELO® (imetelstat) in Lower-risk Myelodysplastic Syndromes (LR-MDS) to be Presented at EHA 2026
First Real-World Evidence Study of RYTELO® (imetelstat) in Lower-risk Myelodysplastic Syndromes (LR-MDS) to be Presented at EHA 2026
Geron Corporation (GERN) Q1 2026 Earnings Call Transcript
Geron (GERN) Reports Q1 Loss, Beats Revenue Estimates
Geron Corporation Reports First Quarter 2026 Financial Results and Recent Business Highlights
Geron Plans to Present at Upcoming Investor Conferences
Geron Plans to Announce First Quarter 2026 Financial Results on May 6, 2026
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Geron Highlights RYTELO Launch, 2026 Revenue Outlook and Phase 3 Myelofibrosis Plans at Needham Conf
Geron Corporation Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Geron Announces Appointment of Timothy Williams as Executive Vice President, Chief Legal Officer and Corporate Secretary
Geron to Participate in the 25th Annual Needham Virtual Healthcare Conference
Geron (NASDAQ:GERN) Share Price Passes Above 200 Day Moving Average – What’s Next?
Geron Announces Appointment of New Members to its Board of Directors
Geron Corporation (NASDAQ:GERN) Given Average Recommendation of “Hold” by Analysts
Geron: Minimal Sales Growth But A Potential Run-Up Ahead
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Almitas Capital LLC Buys Shares of 946,323 Geron Corporation $GERN
Geron Corporation (GERN) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
Geron: Why I'm Doubling Down On My 'Sell' Rating After Q4 Earnings
Geron (GERN) Reports Q4 Loss, Misses Revenue Estimates
Geron Corporation (GERN) Q4 2025 Earnings Call Transcript
Geron Corporation Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights
Geron Plans to Present at Upcoming Investor Conferences
Geron (NASDAQ:GERN) Shares Down 6% – What’s Next?
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Geron Plans to Announce Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026
CG Oncology (NASDAQ:CGON) and Geron (NASDAQ:GERN) Head-To-Head Comparison
Geron: Underpromise And Overdeliver Could Be The 2026 Strategy (Rating Upgrade)
Geron Corporation Provides 2026 Financial Guidance
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Geron Corporation Announces Strategic Restructuring Plan to Position the Company for Long-Term Value Creation
Geron Corporation Presents New Data at ASH 2025 Highlighting the Relationship Between Treatment-Emergent Cytopenias and Clinical Benefit of RYTELO® (Imetelstat) in Lower-Risk MDS
Blood Cancer Therapeutics Reach Critical Commercial and Clinical Inflection Points
Stock Traders Purchase Large Volume of Put Options on Geron (NASDAQ:GERN)
Geron: Rytelo Launch Stalls Out, EU Partnership And IMpactMF Results Could Help
Geron Corporation (GERN) Q3 2025 Earnings Call Transcript
Geron (GERN) Reports Q3 Loss, Lags Revenue Estimates
Geron Corporation Reports Third Quarter 2025 Financial Results and Recent Business Highlights
Geron Corporation Announces Five Presentations Selected for ASH 2025 Highlighting Clinical Activity of RYTELO® (imetelstat) in Myeloid Hematologic Malignancies
Geron (GERN) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release